An example is the siRNN targeting Polo-like kinase 1 (Plk1), which is highly overexpressed in pediatric patients with B-cell acute lymphoblastic leukemia (B-ALL). The gene discussed is PLK1; the disease is B-cell acute lymphoblastic leukemia.